Work

Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer

Year: 2007

Type: article

Abstract: To the Editor Tumor Lysis Syndrome (TLS) is a metabolic complication usually arising from treatment of rapidly proliferating and drug-sensitive neoplasms. It comprises a number of metabolic abnorma...

Source: Acta Oncologica

DOI: 10.1080/02841860701460533

Authors: Marcus Hentrich, Xaver Schiel, Birgit Scheidt, Michael Reitmeier, Ulrike Hoffmann, Ludwig Lutz

Institutions: München Klinik Harlaching, Ludwig-Maximilians-Universität München

Language: English

Topic: Methemoglobinemia and Tumor Lysis Syndrome

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W2025027682

FWCI: 0.287

Cites: 7

Cited by: 17

Related to: 10